Agranulocytosis
19 drugs776 FAERS reportsMedDRA PT
GET
/api/v1/reaction/agranulocytosisReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D000380
A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
Source: U.S. National Library of Medicine — MeSH (Agranulocytosis)
Drugs reporting Agranulocytosis (19)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Cobamamide114%
- 2Ferrous Cysteine Glycinate114%
- 3Magnesium Ascorbate114%
- 4Nadh114%
- 5Pyridoxal114%
- 6Threonate114%
- 7Zinc Ascorbate114%
- 8Lactobionate1812%
- 9Deferiprone1585.4%
- 10Telisotuzumab24.4%
- 11Pralidoxime13.8%
- 12Eflapegrastim13.6%
- 13Methimazole2533.3%
- 14Ceftaroline253.3%
- 15Ceftaroline Fosamil253.3%
- 16Propylthiouracil592.9%
- 17Daptomycin2022.3%
- 18Idarubicin242.2%
- 19Caffeic Acid12.0%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Anxiety Disorder7 shared · 0.37
- Catheter Site Irritation7 shared · 0.37
- Foot Operation7 shared · 0.37
- Infusion Site Urticaria7 shared · 0.37
- Parkinson^s Disease Psychosis7 shared · 0.37
- Catheter Site Erythema7 shared · 0.35
- Maternal Exposure Timing Unspecified7 shared · 0.35
- Prescribed Overdose8 shared · 0.30
- Dysarthria7 shared · 0.29
- Clostridium Difficile Infection7 shared · 0.27
Literature
Recent PubMed references pinned to Agranulocytosis as a MeSH major topic. About the reaction term itself — not about any specific drug.
- High donor hemoglobin interacts with pre-transplant recipient neutropenia to modulate mortality after allogeneic hematopoietic stem cell transplantation: An exploratory, single-center, retrospective, real-world study.PloS one · 2026 · Eslami M, Mehrabi M, Payandeh M, et al.PMID 42172258DOI 10.1371/journal.pone.0349615
- [Chinese guidelines for the clinical application of antibacterial drugs for febrile neutropenia (2026)].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026 · Chinese Society of Hematology, Chinese Medical Association, Chinese Medical Doctor Association, Hematology BranchPMID 42161653DOI 10.3760/cma.j.cn121090-20260120-00041
- Mapping supportive-care evidence for febrile neutropenia prevention in breast cancer chemotherapy: a bibliometric analysis of long-acting G-CSF prophylaxis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026 · Li S, Shang Y, Yuan X, et al.PMID 42149261DOI 10.1007/s00520-026-10780-1
- MASCC score and neutropenic complications: what is the likelihood?Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026 · Davis MPPMID 42142265DOI 10.1007/s00520-026-10786-9
- Plasma Mid-Regional Pro-adrenomedullin as a Prognostic Biomarker in Hematopoietic Stem Cell Transplant Recipients with Febrile Neutropenia.Biological & pharmaceutical bulletin · 2026 · Iwao M, Tanaka R, Shiraiwa K, et al.PMID 42128870DOI 10.1248/bpb.b25-00750
- Evaluating emerging molecular diagnostics for severe infections in neutropenic patients with hematological malignancies.Expert review of molecular diagnostics · 2026 · Liborio MP, Peri AM, Harris PNA, et al.PMID 42112573DOI 10.1080/14737159.2026.2667917
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.